NEWS

August 31, 2010

The Importance of Clinical Trials

August 27, 2010

Laser Based Focal Ablation of Low Grade Prostate Cancer

August 19, 2010

Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer

August 9, 2010

Aragon Pharmaceuticals doses first patient in Phase 1/2 clinical trial of ARN-509 for castration-resistant prostate cancer

August 5, 2010

Aeterna Zentaris Announces NIH Grant for a Phase 1/2 Study in Advanced Prostate Cancer with AEZS-108

July 27, 2010

New Clinical Trial Offers Vascular-Targeted Photodynamic Therapy to Patients with Localized Prostate Cancer

July 14, 2010

Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer

Leuprolide Acetate or Goserelin With or Without GDC-0449 Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

June 30, 2010

Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer

June 29, 2010

FDA approves (Provenge) vaccine to treat prostate cancer

Featured Clinical Trial

Featured Cancer Center

All form fields are required.

All form fields are required.















All form fields are required.